Abstract:Objective::Optimal luteinizing hormone (LH) levels for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) patients following the gonadotropin-releasing hormone (GnRH) antagonist protocol remain controversial. This study aimed to estimate the association between serum LH levels on the triggering day (LHLOT) and clinical pregnancy outcomes in IVF/ICSI patients following the GnRH antagonist protocol. Methods::We enrolled 4743 IVF/ICSI cycles using flexible or fixed GnRH antagonist protocols between January 2017 and June 2021. The patients were stratified into four groups according to the LHLOT quartiles (Q1–Q4). Each group was further divided into two subgroups according to the median basal LH/LHLOT. The main outcomes were clinical pregnancy, birth, and miscarriage rates. Secondary outcomes were oocyte yield, number of MII, fertilized oocytes (2PN), and high-quality embryos.Results::Serum LHLOT levels were negatively correlated with oocyte yield and the numbers of MII, 2PN, and high-quality embryos. Reproductive outcomes were compared among the different quartiles and subgroups. The absolute difference in the clinical pregnancy rates between the Q4 and Q1 groups was 6.4% (47.2% vs. 40.8%, P <0.05). Clinical pregnancy rates between the subgroups with basal LH/LHLOT >3.04 and ≤3.04 were 32.7% and 48.6% ( P <0.01), respectively, in Q1. Within Q3, the clinical pregnancy rates between the subgroups with basal LH/LHLOT >2.14 and ≤2.14 were 50.2% and 41.9%, respectively ( P <0.05). The greater the decrease in LH levels, the lower the oocyte maturation rate across all quartiles. Conclusions::According to the LHLOT quartiles, the Q1 of serum LHLOT <1.43 IU/L may result in a higher number of oocytes but reduced oocyte maturation and lower clinical pregnancy rates. A decrease in LH levels by approximately 2.14 to 3.04 times compared to basal LH levels may lead to higher clinical pregnancy rates in IVF/ICSI patients following the GnRH antagonist protocol.

Double Measurements of Serum HCG Concentration and Its Ratio May Predict IVF Outcome.

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

The predictive value of a si ngle beta human chorionic gonadotropin determination in pregnancies achieved by assisted reproductive technology

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Association Between Luteinizing Hormone Level Decrease on the Triggering Day and Pregnancy Outcome for in Vitro Fertilization/intracytoplasmic Sperm Injection Patients Following Gonadotropin-Releasing Hormone Antagonist Protocol: a Retrospective Cohort Study

Serum Human Chorionic Gonadotropin Level Measured 17 Days after Oocyte Retrieval Can Predict Final Clinical Pregnancy Outcomes in IVF/ICSI Treatment Cycles.

Paired Detection of Serum Human Chorionic Gonadotropin Possibly Predicting Pregnant Outcome after in Vitro Fertilization-a Large Scale Retrospective Research

The Value of HCG Serum Concentrations after Trigger in Predicting Pregnancy and Live Birth Rates in IVF–ICSI

Serum human chorionic gonadotropin measured 7 days following day 3 embryo transfer might predict pregnancy outcome in IVF.

Value of Serum Β-Hcg on the 14 Th Day after Embryo Transfer in Predicting Pregnancy Outcome

Combined analysis of human chorionic gonadotrophin concentrations at different time points after frozen-thawed blastocyst transfer can improve our ability to predict the pregnancy outcomes of single gestations

Serum Progesterone Concentration on Day of HCG Administration and IVF Outcome

Serum Beta Human Chorionic Gonadotropin Levels on Day 12 after in Vitro Fertilization in Predicting Final Type of Clinical Pregnancy.

Predictive value of serum β-human chorionic gonadotropin for early pregnancy outcomes

Serum Estradiol Level and Progesterone/Estradiol Ratio Per Follicle on HCG Administration Day in Relation to Outcomes of in Vitro Fertilization and Embryo Transfer

The Role of Serum AMH and FF AMH in Predicting Pregnancy Outcome in the Fresh Cycle of IVF/ICSI: a Meta-Analysis.

Increased Maternal Serum Hcg Concentrations in the Presence of a Female Fetus As Early As 2 Weeks after IVF-ET.

Serum LH Level on the Day of hCG Administration as a Predictor of the Reproductive Outcomes in Ovulation Induction Cycle Frozen-Thawed Embryo Transfer

Comparison of serum human chorionic gonadotropin beta-subunit levels on day 14 after in vitro maturation of immature eggs,in vitro fertilization and embryo transfer

Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation

Effects of Different Fertilizations Upon Serum HCG Level of IVF Versus ET in Early Pregnancy